Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol
Objective. By assessing its circulating concentrations in type 2 diabetes mellitus (T2DM) patients, we aimed to explore the associations of betatrophin with various metabolic parameters and evaluate its diagnostic value in T2DM. Methods. A total of 58 non-diabetes-mellitus (NDM) subjects and 73 age-...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2015/479157 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832556998586007552 |
|---|---|
| author | Min Yi Rong-ping Chen Rui Yang Xian-feng Guo Jia-chun Zhang Hong Chen |
| author_facet | Min Yi Rong-ping Chen Rui Yang Xian-feng Guo Jia-chun Zhang Hong Chen |
| author_sort | Min Yi |
| collection | DOAJ |
| description | Objective. By assessing its circulating concentrations in type 2 diabetes mellitus (T2DM) patients, we aimed to explore the associations of betatrophin with various metabolic parameters and evaluate its diagnostic value in T2DM. Methods. A total of 58 non-diabetes-mellitus (NDM) subjects and 73 age- and sex-matched newly diagnosed T2DM patients were enrolled. Correlation analyses between circulating betatrophin levels and multiple metabolic parameters were performed. Receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic value of betatrophin concentration in T2DM. Results. Circulating betatrophin levels were approximately 1.8 times higher in T2DM patients than in NDM individuals (median 747.12 versus 407.41 pg/mL, P<0.001). Correlation analysis showed that betatrophin was negatively associated with high-density lipoprotein cholesterol (HDL-C) levels in all subjects. ROC curve analysis identified betatrophin as a potent diagnostic biomarker for T2DM. The optimal cut-off point of betatrophin concentration for predicting T2DM was 501.23 pg/mL. Conclusions. Serum betatrophin levels were markedly increased in newly diagnosed T2DM patients and further elevated in obese T2DM subjects. Betatrophin was negatively correlated with HDL-C levels. Our findings indicate that betatrophin could be a potent diagnostic biomarker for T2DM. |
| format | Article |
| id | doaj-art-f86b5bc84cf743abaf88f9006dc1da28 |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-f86b5bc84cf743abaf88f9006dc1da282025-02-03T05:43:53ZengWileyInternational Journal of Endocrinology1687-83371687-83452015-01-01201510.1155/2015/479157479157Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-CholesterolMin Yi0Rong-ping Chen1Rui Yang2Xian-feng Guo3Jia-chun Zhang4Hong Chen5Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, ChinaObjective. By assessing its circulating concentrations in type 2 diabetes mellitus (T2DM) patients, we aimed to explore the associations of betatrophin with various metabolic parameters and evaluate its diagnostic value in T2DM. Methods. A total of 58 non-diabetes-mellitus (NDM) subjects and 73 age- and sex-matched newly diagnosed T2DM patients were enrolled. Correlation analyses between circulating betatrophin levels and multiple metabolic parameters were performed. Receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic value of betatrophin concentration in T2DM. Results. Circulating betatrophin levels were approximately 1.8 times higher in T2DM patients than in NDM individuals (median 747.12 versus 407.41 pg/mL, P<0.001). Correlation analysis showed that betatrophin was negatively associated with high-density lipoprotein cholesterol (HDL-C) levels in all subjects. ROC curve analysis identified betatrophin as a potent diagnostic biomarker for T2DM. The optimal cut-off point of betatrophin concentration for predicting T2DM was 501.23 pg/mL. Conclusions. Serum betatrophin levels were markedly increased in newly diagnosed T2DM patients and further elevated in obese T2DM subjects. Betatrophin was negatively correlated with HDL-C levels. Our findings indicate that betatrophin could be a potent diagnostic biomarker for T2DM.http://dx.doi.org/10.1155/2015/479157 |
| spellingShingle | Min Yi Rong-ping Chen Rui Yang Xian-feng Guo Jia-chun Zhang Hong Chen Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol International Journal of Endocrinology |
| title | Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol |
| title_full | Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol |
| title_fullStr | Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol |
| title_full_unstemmed | Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol |
| title_short | Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol |
| title_sort | betatrophin acts as a diagnostic biomarker in type 2 diabetes mellitus and is negatively associated with hdl cholesterol |
| url | http://dx.doi.org/10.1155/2015/479157 |
| work_keys_str_mv | AT minyi betatrophinactsasadiagnosticbiomarkerintype2diabetesmellitusandisnegativelyassociatedwithhdlcholesterol AT rongpingchen betatrophinactsasadiagnosticbiomarkerintype2diabetesmellitusandisnegativelyassociatedwithhdlcholesterol AT ruiyang betatrophinactsasadiagnosticbiomarkerintype2diabetesmellitusandisnegativelyassociatedwithhdlcholesterol AT xianfengguo betatrophinactsasadiagnosticbiomarkerintype2diabetesmellitusandisnegativelyassociatedwithhdlcholesterol AT jiachunzhang betatrophinactsasadiagnosticbiomarkerintype2diabetesmellitusandisnegativelyassociatedwithhdlcholesterol AT hongchen betatrophinactsasadiagnosticbiomarkerintype2diabetesmellitusandisnegativelyassociatedwithhdlcholesterol |